Aviance Capital Partners, LLC Pfizer Inc Transaction History

Aviance Capital Partners, LLC

$720 Million
Q2 2025

A detailed history of Aviance Capital Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Aviance Capital Partners, LLC holds 98,576 shares of PFE stock, worth $2.67 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

98,576

Previous 99,695 1.12%

Holding current value

$2.67 Million

Previous $2.53 Million 5.42%

% of portfolio

0.33%

Previous 0.37%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	SELL	$21.59 - $24.84 $24,159 - $27,795	-1,119 Reduced 1.12%	98,576 $2.39 Million
Q1 2025 Apr 28, 2025	SELL	$25.01 - $27.13 $989,920 - $1.07 Million	-39,581 Reduced 28.42%	99,695 $2.53 Million
Q4 2024 Feb 06, 2025	BUY	$24.8 - $30.19 $1.26 Million - $1.53 Million	50,713 Added 57.26%	139,276 $3.69 Million
Q3 2024 Nov 07, 2024	SELL	$27.7 - $31.39 $31,993 - $36,255	-1,155 Reduced 1.29%	88,563 $2.56 Million
Q2 2024 Aug 09, 2024	SELL	$25.26 - $29.6 $48,903 - $57,305	-1,936 Reduced 2.11%	89,718 $2.51 Million
Q1 2024 Apr 17, 2024	BUY	$25.89 - $29.73 $651,547 - $748,185	25,166 Added 37.85%	91,654 $2.54 Million
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $59,210 - $76,908	-2,266 Reduced 3.3%	66,488 $1.91 Million
Q3 2023 Nov 06, 2023	SELL	$32.09 - $37.51 $47,204 - $55,177	-1,471 Reduced 2.09%	68,754 $2.28 Million
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $614 - $710	17 Added 0.02%	70,225 $2.58 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $94,496 - $123,020	2,399 Added 3.54%	70,208 $2.86 Million
Q4 2022 Feb 06, 2023	BUY	$41.75 - $54.5 $30,227 - $39,458	724 Added 1.08%	67,809 $3.48 Million
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $36,277 - $44,285	-829 Reduced 1.22%	67,085 $2.94 Million
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $604 - $717	13 Added 0.02%	67,914 $3.56 Million
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $13,542 - $16,780	-296 Reduced 0.43%	67,901 $3.52 Million
Q4 2021 Feb 07, 2022	BUY	$41.32 - $61.25 $413 - $612	10 Added 0.01%	68,197 $4.03 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $35,442 - $45,529	903 Added 1.34%	68,187 $2.93 Million
Q2 2021 Aug 06, 2021	SELL	$35.91 - $40.68 $9,695 - $10,983	-270 Reduced 0.4%	67,284 $2.64 Million
Q1 2021 Apr 29, 2021	BUY	$33.49 - $37.77 $13,898 - $15,674	415 Added 0.62%	67,554 $2.45 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $4,585 - $5,830	137 Added 0.2%	67,139 $2.47 Million
Q3 2020 Nov 03, 2020	BUY	$31.75 - $37.25 $1,270 - $1,490	40 Added 0.06%	67,002 $2.46 Million
Q2 2020 Jul 24, 2020	BUY	$30.12 - $36.54 $13,975 - $16,954	464 Added 0.7%	66,962 $2.19 Million
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $72,548 - $103,656	-2,684 Reduced 3.88%	66,498 $2.17 Million
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $28,113 - $31,905	854 Added 1.25%	69,182 $2.71 Million
Q3 2019 Nov 07, 2019	BUY	$32.49 - $42.13 $14,230 - $18,452	438 Added 0.65%	68,328 $2.46 Million
Q2 2019 Aug 12, 2019	SELL	$36.98 - $41.52 $54,582 - $61,283	-1,476 Reduced 2.13%	67,890 $2.94 Million
Q1 2019 May 01, 2019	BUY	$37.5 - $41.2 $7,050 - $7,745	188 Added 0.27%	69,366 $2.95 Million
Q4 2018 Feb 11, 2019	BUY	$38.47 - $43.86 $4,000 - $4,561	104 Added 0.15%	69,178 $3.02 Million
Q3 2018 Nov 09, 2018	BUY	$34.47 - $41.81 $21,647 - $26,256	628 Added 0.92%	69,074 $3.04 Million
Q1 2018 May 03, 2018	SELL	$31.91 - $37.02 $62,958 - $73,040	-1,973 Reduced 2.8%	68,446 $2.43 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $9,645 - $10,234	-290 Reduced 0.41%	70,419 $2.55 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $2.19 Million - $2.41 Million	70,709	70,709 $2.52 Million

Others Institutions Holding PFE

# of Institutions

3,295

Shares Held

3.66B

Call Options Held

96M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $152B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviance Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviance Capital Partners, LLC with notifications on news.

Account

Aviance Capital Partners, LLC Pfizer Inc Transaction History